No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
RFK Jr. Could Prove a Surprise Boon for Stem-cell Stocks With Pivotal Year Ahead
Stem Cells Poised for Success in 2025 as Regulatory Environment Looks More Favorable -- Market Talk
JonesTrading Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $40
12 Health Care Stocks Moving In Thursday's Pre-Market Session
America's Car-Mart Posts Upbeat Sales, Joins Methode Electronics, Verint Systems, Brown-Forman And Other Big Stocks Moving Higher On Thursday
Capricor Therapeutics to Present at Upcoming Investor Conferences
Unlock the Full List